irasia.com - Investor Relations Asia Pacific
HOME

The United Laboratories International Holdings Limited

Press Releases       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2009-December-13
  • TUL Obtained Products Approval for Recombinant Human Insulin Product, Full Sights on the Multi-billion Market (in PDF)
  • 2009-November-13
  • TUL Obtained Products Approval for Two New Eye Drops Products (in PDF)
  • 2009-November-10
  • TUL Acquired FDA Approval for its Product, Planned to Enter US Market (in PDF)
  • 2009-September-9
  • The Group Recorded the Highest Ever Sales of HK$2.1B, Capture Opportunities Arising from National Policies to Foster Long Term Growth (in PDF)
  • 2009-May-4
  • New Medicine Specializes in Treatment of Influenza Virus Type A Obtained Production Approval (in PDF)
  • 2009-April-19
  • Market Launch of Acetaminophen and Dextromethorphan Hydrobromide Oral Solution - New Medicine Specializes in Treatment of Influenza and Cough (in PDF)
  • 2009-April-8
  • The United Laboratories International Holdings Limited Announces 2008 Annual Results (in PDF)
  • 2009-March-23
  • TUL's Products Acquired International Standard Accreditation Once Again Granted EU Certificate of Suitability (in PDF)
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2010
  • 2010 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2012 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.